Cannabis is becoming mainstream. Because of this, people are starting to learn that it holds many different medical attributes. Research and studies in countries around the world confirm what advocates in the United States are arguing with lawmakers. Lawmakers state that cannabis needs more research. Apparently, US lawmakers are not familiar with the US National Library of Medicine National Institutes of Health or the NCBI.
The U.S. Government Already Holds a Cannabis Patent
If they were, they would be able to read countless reports of studies that support cannabis as an effective medicine. Apparently, someone in the United States government understands the potential for this medicine otherwise the United States patent office would never have issued patent number 6630507 which is the property of the United States Health and Human Services.
The patent is for cannabinoids as antioxidants and neuroprotectants. Supporting this patent, the NCBI has a study published titled, “THC and gabapentin interactions in a mouse neuropathic pain model.” The research was done in a controlled environment by medical professionals. In abstract, they concluded THC improves the therapeutic window.
The Conclusion Simplified
This means that phytocannabinoids such as THC can increase the effectiveness of pain medication. Which, is excellent news for medical patients. Why you may ask? Because, this means THC could effectively reduce the amount of pharmaceuticals a patient needs to take to obtain effective results. In addition, those who are only seeing partial benefits could see substantially more benefits from their medication by incorporating delta-9-tetrahydrocannabinol or THC for short into their regimen.
The Study’s Conclusion in Scientific Terms
Some of the studies about cannabis are amazing. This happens to be one of them. To quote the study,
“Coadministration of THC and gabapentin in a fixed-ratio dose-dependently reduced mechanical and cold allodynia, and produced all the side-effects observed for THC, including motor incoordination, catalepsy and sedation. Isobolographic analysis indicated that the ED50 for the THC: gabapentin induced reduction in allodynia was 1.7 times less than that predicted for an additive interaction. The therapeutic window of combination THC: gabapentin was greater than that for THC alone.”
I’m not so sure about anyone else, but for those who say cannabis is for lazy stoners, I do believe you are mistaken. The science behind cannabinoid medicine is amazing. As more research is becoming available, the world of cannabinoid-based medicine is starting to intrigue the medical community as well as medical patients around the world. This is excellent news for the many individuals that suffer from chronic pain globally.